Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety Evaluation of Prismocitrate 18 in Patients Receiving Continuous Renal Replacement Therapy (CRRT)

NCT05399537 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT05399537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05399537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety Evaluation of Prismocitrate 18 in Patients Receiving Continuous Renal Replacement Therapy (CRRT)
Lead sponsor
Vantive Health LLC
Phase
Phase 3
Overall status
Recruiting
Start date
July 12, 2024
Completion date
January 31, 2027
Enrollment
40 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury (aki), continuous renal replacement therapy (crrt), regional citrate anticoagulation (rca)